<SEC-DOCUMENT>0001193125-23-232585.txt : 20230911
<SEC-HEADER>0001193125-23-232585.hdr.sgml : 20230911
<ACCEPTANCE-DATETIME>20230911171553
ACCESSION NUMBER:		0001193125-23-232585
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20230911
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230911
DATE AS OF CHANGE:		20230911

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sight Sciences, Inc.
		CENTRAL INDEX KEY:			0001531177
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				800625749
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40587
		FILM NUMBER:		231248463

	BUSINESS ADDRESS:	
		STREET 1:		3000 SAND HILL ROAD
		STREET 2:		BUILDING 3, SUITE 105
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025
		BUSINESS PHONE:		(415) 889-0550

	MAIL ADDRESS:	
		STREET 1:		3000 SAND HILL ROAD
		STREET 2:		BUILDING 3, SUITE 105
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d507422d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sght="http://www.sightsciences.com/20230911" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2023-09-11_to_2023-09-11">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2023-09-11_to_2023-09-11">0001531177</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="sght-20230911.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2023-09-11_to_2023-09-11"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001531177</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-09-11</xbrli:startDate> <xbrli:endDate>2023-09-11</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2023-09-11_to_2023-09-11">8-K</ix:nonNumeric></span></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2023-09-11_to_2023-09-11" format="ixt:datemonthdayyearen">September&#160;11, 2023</ix:nonNumeric></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2023-09-11_to_2023-09-11">Sight Sciences, Inc.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of Registrant as Specified in Its Charter)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2023-09-11_to_2023-09-11" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2023-09-11_to_2023-09-11">001-40587</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2023-09-11_to_2023-09-11">80-0625749</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(State or Other Jurisdiction<br />of Incorporation)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(IRS Employer<br />Identification No.)</span></td></tr></table> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:48%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2023-09-11_to_2023-09-11">4040 Campbell</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2023-09-11_to_2023-09-11">Avenue</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine3" contextRef="duration_2023-09-11_to_2023-09-11">Suite 100</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2023-09-11_to_2023-09-11">Menlo Park</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2023-09-11_to_2023-09-11" format="ixt-sec:stateprovnameen">California</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2023-09-11_to_2023-09-11">94025</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of Principal Executive Offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s Telephone Number, Including Area Code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2023-09-11_to_2023-09-11">(877)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2023-09-11_to_2023-09-11">266-1144</ix:nonNumeric></span></p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">N/A</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former Name or Former Address, if Changed Since Last Report)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2023-09-11_to_2023-09-11" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2023-09-11_to_2023-09-11" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2023-09-11_to_2023-09-11" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2023-09-11_to_2023-09-11" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br />Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br />on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-09-11_to_2023-09-11">Common Stock, $0.001 par value per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-09-11_to_2023-09-11">SGHT</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2023-09-11_to_2023-09-11" format="ixt-sec:exchnameen">The Nasdaq Global Select Market</ix:nonNumeric></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 (&#167; <span style="white-space:nowrap">240.12b-2</span> of this chapter).</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2023-09-11_to_2023-09-11" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;<ix:nonNumeric name="dei:EntityExTransitionPeriod" contextRef="duration_2023-09-11_to_2023-09-11" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;5.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Appointment of Chief Commercial Officer </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Effective September&#160;11, 2023, Matthew Link was appointed by the board of directors (the &#8220;Board&#8221;) of Sight Sciences, Inc. (the &#8220;Company&#8221;) to serve as the Company&#8217;s Chief Commercial Officer. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Biographical Information </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&#160;Link, 48, has more than 20 years of experience building teams and leading innovation in the healthcare and medical technology industries, most recently serving as Managing Partner at Orion Healthcare Advisors, LLC, a consulting services provider, since 2021. Before Orion, Mr.&#160;Link spent nearly 15 years in regional and executive leadership positions at NuVasive, Inc. (&#8220;NuVasive&#8221;), a global leader in surgical implants and enabling technology for spine surgery and orthopedics, where he designed and executed strategies that supported the company&#8217;s revenue growth from less than $100&#160;million to over $1&#160;billion. Mr.&#160;Link joined NuVasive as an Area Business Manager in 2006 and rose to the level of President where his responsibilities included oversight of global business units in spine, neurophysiology and orthopedics from 2018 to 2021. Prior to NuVasive, Mr.&#160;Link held commercial leadership roles at Depuy Orthopedics and Depuy Spine. He currently serves as a member of the board of directors of Springbok Analytics, Fibrobiologics and DinamicOR. Additionally, he serves on the board of directors of the Coulter Translational Research Endowment at the University of Virginia. Mr.&#160;Link received a BSEd in Physical Education and Sports Medicine from the University of Virginia. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Employment Agreement </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with his appointment as Chief Commercial Officer, Mr.&#160;Link entered into an employment agreement with the Company (the &#8220;Employment Agreement&#8221;) effective September&#160;11, 2023. Pursuant to the terms of the Employment Agreement, Mr.&#160;Link will receive an initial annual base salary of $410,000 (such annual base salary, as may be adjusted by the Board from time to time, the &#8220;Base Salary&#8221;) and will be eligible to receive an initial annual cash bonus, targeted at 50% of his Base Salary (such target, as may be adjusted by the Board from time to time, the &#8220;Annual Bonus&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If Mr.&#160;Link&#8217;s employment is terminated by the Company without cause or Mr.&#160;Link resigns from the Company with good reason, the Company shall: (a)&#160;pay Mr.&#160;Link an amount equal to the Base Salary for the subsequent <span style="white-space:nowrap">12-month</span> period, (b)&#160;pay Mr.&#160;Link an amount equal to any unpaid Annual Bonus earned for the year prior to the year of termination, payable when annual bonuses for such year are paid to other executives of the Company, and (c)&#160;make direct payment of, or reimbursement for, the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&#8220;COBRA&#8221;) premiums, less the amount the Mr.&#160;Link would have paid for coverage as an active employee, commencing on Mr.&#160;Link&#8217;s separation date and ending upon the earliest of: (i)&#160;the expiration of the subsequent <span style="white-space:nowrap">12-month</span> period, (ii)&#160;the date Mr.&#160;Link and/or his dependents become no longer eligible for COBRA, or (iii)&#160;the date Mr.&#160;Link becomes eligible to receive benefits from a subsequent employer. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Employment Agreement, &#8220;cause&#8221; generally means, subject to notice and cure rights, Mr.&#160;Link&#8217;s: (a)&#160;refusal to substantially perform duties or carry out reasonable and lawful instructions concerning duties, (b)&#160;material breach of a policy of the Company, provision of the Employment Agreement or any other material agreement between the executive officer and the Company, (c)&#160;conviction, plea of no contest, plea of nolo contendere, or imposition of unadjudicated probation for any felony or crime involving moral turpitude, (d)&#160;unlawful use or possession of illegal drugs on the Company&#8217;s (or any of its affiliate&#8217;s) premises or while performing the executive officer&#8217;s duties and responsibilities under the Employment Agreement, or (e)&#160;commission of an act of fraud, embezzlement, misappropriation, willful misconduct or breach of fiduciary duty against the Company or any of its affiliates. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Employment Agreement, &#8220;good reason&#8221; generally means, subject to notice and cure rights: (a)&#160;a reduction in Base Salary or target Annual Bonus, (b)&#160;a material decrease in authority or areas of responsibility, (c)&#160;the relocation of Mr.&#160;Link&#8217;s primary office to a location more than 35 miles from his primary office as of the date of the Employment Agreement, (d)&#160;the failure of any successor of all or substantially all of the Company&#8217;s assets to assume the Employment Agreement, to the extent such assumption does not occur automatically by operation of law, or (e)&#160;the Company&#8217;s breach of a material provision of the Employment Agreement. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing description of the Employment Agreement does not purport to be complete and is subject to and qualified in its entirety by reference to the full and complete text of the Employment Agreement, which shall be attached as an exhibit to the Company&#8217;s Quarterly Report on Form <span style="white-space:nowrap">10-Q</span> for the quarter ending September&#160;30, 2023. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Equity Grants </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, in connection with Mr.&#160;Link&#8217;s appointment as Chief Commercial Officer, the Board approved the following equity grants pursuant to the Company&#8217;s 2021 Incentive Award Plan (the &#8220;Plan&#8221;): (a) an Option (as defined in the Plan) to purchase shares of common stock with an aggregate value of $660,000, and (b)&#160;an award of restricted stock units with an aggregate value of $1,540,000, in each case subject to the terms and conditions of the Plan and the related award agreements. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Relationships and Transactions </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with his appointment as Chief Commercial Officer, Mr.&#160;Link entered into the Company&#8217;s standard indemnification agreement for directors and officers. Mr.&#160;Link has no family relationships with any director or executive officer of the Company. There are no arrangements or understandings between Mr.&#160;Link and any other person pursuant to which Mr.&#160;Link was appointed as an executive officer. Additionally, there are no transactions involving Mr.&#160;Link that would require disclosure under Item 404(a) of Regulation <span style="white-space:nowrap">S-K.</span> </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;7.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Regulation FD Disclosure </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&#160;11, 2023, the Company issued a press release announcing the appointment of Mr.&#160;Link as discussed above. The Company also issued a press release providing revenue guidance for the third quarter ending September&#160;30, 2023 and updating its revenue guidance for the fiscal year ending December&#160;31, 2023. A copy of the press releases are furnished as Exhibits 99.1 and 99.2, respectively, to this Current Report on Form <span style="white-space:nowrap">8-K,</span> and incorporated into this Item 7.01 by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information in this Item 7.01, including Exhibits 99.1 and 99.2 attached hereto, is being furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section. Such information shall not be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing, except as otherwise expressly set forth by specific reference in such filing. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Exhibits </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"><span style="font-weight:bold">Exhibit<br />No.</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Description of Exhibit</span></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d507422dex991.htm">Press Release, dated September&#160;11, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d507422dex992.htm">Press Release, dated September&#160;11, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Sight Sciences, Inc.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: September&#160;11, 2023</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Alison Bauerlein</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Chief Financial Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d507422dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g507422g0912011754621.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sight Sciences Appoints Matt Link as Chief Commercial Officer </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Former NuVasive President helped scale high-growth medical device company to over $1&nbsp;billion in revenue </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>MENLO PARK, Calif. - September 11, 2023 -</B> (GLOBE NEWSWIRE) &#150; Sight Sciences, Inc. (Nasdaq: SGHT) (&#147;Sight Sciences,&#148; or the
&#147;Company&#148;), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patients&#146; lives, today announced the appointment of Matthew Link as its Chief Commercial
Officer, effective September&nbsp;11, 2023. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We are very excited to have Matt join Sight Sciences as we scale our Surgical Glaucoma and Dry Eye
businesses. Matt is a highly talented medtech business leader with a track record of success in transforming treatment paradigms with disruptive new technology, and predictably scaling in a public high-growth medtech setting. We believe his market
development experience with procedurally focused, less invasive solutions utilizing disruptive technology that transformed spine surgery positions him well to accelerate the procedural transformation of glaucoma and dry eye disease treatment with
our interventional OMNI<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Surgical System and TearCare<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> System technologies. Matt joined NuVasive at a time when it had similar revenue
levels as Sight Sciences does today and helped scale NuVasive&#146;s business over the ensuing years to profitability with over $1&nbsp;billion in revenue,&#148; said Paul Badawi, Founder and Chief Executive Officer of Sight Sciences. &#147;We are
confident Matt&#146;s addition will further enhance the capabilities of our strong executive team. We are looking forward to him leading the commercial organization, advancing our strategic plans, and ensuring we have the appropriate infrastructure
to support significant and profitable growth over the coming years.&#148;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Link added, &#147;I am delighted to be joining Sight Sciences at this
critical juncture as the glaucoma and dry eye categories are undergoing significant transformation. Sight Sciences is a leader in eyecare technology innovation with a portfolio and pipeline of products that are elevating the standard of care. I am
ready to leverage my strong commercial strategy and development background in high-growth medtech to help Sight Sciences achieve its fullest potential. I look forward to working with Paul and the Sight Sciences team to improve the lives of our
patients and help the Company achieve its growth and profitability objectives.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Link has more than 20 years of experience building teams
and leading innovation in the healthcare and medical technology industries, most recently serving as Managing Partner at Orion Healthcare Advisors, LLC, a consulting services provider. Before Orion, Mr.&nbsp;Link spent nearly 15 years in regional
and executive leadership positions at NuVasive, Inc., a global leader in surgical implants and enabling technology for spine surgery and orthopedics, where he designed and executed strategies that supported the company&#146;s revenue growth from
less than $100&nbsp;million to over $1&nbsp;billion.&nbsp;Mr.&nbsp;Link joined NuVasive as an Area Business Manager and rose to the level of President where his responsibilities included oversight of global business units in spine, neurophysiology
and orthopedics. Prior to NuVasive, Mr.&nbsp;Link held commercial leadership roles at Depuy Orthopedics and Depuy Spine.&nbsp;He currently serves as a member of the board of directors of Springbok Analytics, Fibrobiologics and
DinamicOR.&nbsp;Additionally, he serves on the board of directors of the Coulter Translational Research Endowment at the University of Virginia. Mr.&nbsp;Link received a BSEd in Physical Education and Sports Medicine from the University of Virginia.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Sight Sciences </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sight Sciences is an eyecare
technology company focused on developing and commercializing innovative solutions to transform care and improve patients&#146; lives. Using minimally invasive or <FONT STYLE="white-space:nowrap">non-invasive</FONT> approaches to target the
underlying causes of the world&#146;s most prevalent eye diseases, Sight Sciences seeks to create more effective treatment paradigms that enhance patient care and supplant conventional, outdated approaches. The Company&#146;s OMNI<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Surgical System is an implant-free glaucoma surgery technology that reduces intraocular pressure in adult patients with primary open-angle glaucoma (POAG), the world&#146;s leading cause of
irreversible blindness. The Company&#146;s TearCare<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> System technology is 510(k) </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g507422g0912011754621.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
cleared for the application of localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland dysfunction (MGD) when used in conjunction with manual expression
of the meibomian glands, enabling office-based clearance of gland obstructions by physicians to address the leading cause of dry eye disease. The Company&#146;s SION<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP> Surgical Instrument is a
manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For more information, visit&nbsp;www.sightsciences.com.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">OMNI and TearCare are registered trademarks of Sight Sciences. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SION is a trademark of Sight Sciences. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><SUP
STYLE="font-size:75%; vertical-align:top">&copy;</SUP> 2023 Sight Sciences. All rights reserved. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release, together with other statements and information publicly disseminated by the Company, contains certain forward-looking statements within the
meaning of Section&nbsp;27A of the Securities Act of 1933, as amended, and Section&nbsp;21E of the Securities Exchange Act of 1934, as amended, which statements are subject to considerable risks and uncertainties. The Company intends such
forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 and includes this statement for purposes of complying with these safe harbor
provisions. Any statements made in this press release that are not statements of historical fact, including statements about our beliefs and expectations, are forward-looking statements and should be evaluated as such. Forward-looking statements
include all statements other than statements of historical fact, including statements concerning the perceived benefits of the Company&#146;s announced Chief Commercial Officer appointment, and should be evaluated as such. These statements often
include words such as &#147;anticipate,&#148; &#147;expect,&#148; &#147;suggests,&#148; &#147;plan,&#148; &#147;believe,&#148; &#147;intend,&#148; &#147;estimates,&#148; &#147;targets,&#148; &#147;projects,&#148; &#147;should,&#148;
&#147;could,&#148; &#147;would,&#148; &#147;may,&#148; &#147;will,&#148; &#147;forecast&#148; and other similar expressions. We base these forward-looking statements on our current expectations, plans and assumptions that we have made in light of
our experience in the industry, as well as our perceptions of historical trends, current conditions, expected future developments and other factors we believe are appropriate under the circumstances at such time. Although management believes these
forward-looking statements are based upon reasonable assumptions at the time they are made, management cannot guarantee their accuracy or completeness. Forward-looking statements are subject to and involve risks, uncertainties and assumptions that
may cause the Company&#146;s actual results, performance or achievements to be materially different from any future results, performance, or achievements predicted, assumed or implied by such forward-looking statements. Some of the risks and
uncertainties that may cause actual results to materially differ from those expressed or implied by these forward-looking statements are discussed under the caption &#147;Risk Factors&#148; in the Company&#146;s filings with the SEC, as may be
updated from time to time in subsequent filings. These cautionary statements should not be construed by you to be exhaustive and are made only as of the date of this press release. Sight Sciences undertakes no obligation to update or revise any
forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor
contact: </B> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Philip Taylor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Gilmartin Group </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">415.937.5406 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investor.Relations@Sightsciences.com</P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>d507422dex992.htm
<DESCRIPTION>EX-99.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.2 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g507422g0912011808138.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sight Sciences Provides Revenue Guidance For the Third Quarter of 2023 and </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Updates Revenue Guidance For Full Year 2023 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MENLO PARK, Calif., September&nbsp;11, 2023 (GLOBE NEWSWIRE) &#150; Sight Sciences, Inc. (Nasdaq: SGHT) (&#147;Sight Sciences,&#148; or the
&#147;Company&#148;), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patients&#146; lives, today announced third quarter 2023 revenue guidance and updated its
revenue guidance for full year 2023. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Third Quarter 2023 Revenue Guidance </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company expects third quarter 2023 total revenue to be in the range of $19.0&nbsp;million to $20.0&nbsp;million. While account retention remains high for
our Surgical Glaucoma segment, the Company has seen reductions in new account additions, and expects year-over-year utilization to decrease in the third quarter, which the Company believes is primarily due to the transitory uncertainty for glaucoma
customers caused by proposed local coverage determinations (&#147;LCDs&#148;). In June 2023, five of the seven Medicare Administrative Contractors (&#147;MACs&#148;) published LCDs that, if finalized as proposed, could identify many <FONT
STYLE="white-space:nowrap">non-implantable</FONT> micro-invasive glaucoma surgery (&#147;MIGS&#148;) procedures, including the Company&#146;s surgical glaucoma technologies, as investigational and <FONT STYLE="white-space:nowrap">non-covered</FONT>
for Medicare beneficiaries in the states covered by these five MACs. The Company expects revenue from its Dry Eye segment to be slightly down sequentially primarily due to typical seasonality patterns coupled with the evolution of the Company&#146;s
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">go-to-market</FONT></FONT> strategy, which emphasizes higher utilization within existing accounts as it nears the execution of its reimbursement strategy in 2024. The Company is
focused on building a higher utilization, recurring revenue business model with a durable repeat customer base and broad market access. While this is expected to result in relatively fewer new accounts added in the period, the Company has seen
positive trends in recurring revenue from existing customers in the third quarter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We typically see a strong second quarter followed by a slower
start to the third quarter given traditional seasonality patterns. While we had a strong second quarter prior to the LCD proposals, we have faced a lower cadence of new account additions and relatively flat utilization and we have not experienced
the expected increase in commercial activity thus far in August and early September. While we are actively managing the proposed LCDs and their impacts on our business and customers, we believe that the ongoing uncertainty from the proposed LCDs has
affected the ordering activity of certain customers in the third quarter. We expect this impact to continue until there is clarity on longer-term coverage by the MACs. We are taking steps intended to mitigate these effects and believe they will
prove to be transitory if our products, especially our OMNI<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Surgical System technology, maintain their current broad coverage upon finalization of the LCDs,&#148; said Paul Badawi, Founder
and Chief Executive Officer of Sight Sciences. &#147;Notably, our account retention remains high, evidencing OMNI&#146;s clinical importance to the glaucoma treatment paradigm. We expect that revenue will normalize and return to growth should the
MACs clarify that OMNI procedures are to remain covered for Medicare beneficiaries in the affected jurisdictions.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We remain steadfast in our
belief in OMNI&#146;s leading clinical value proposition and are confident that we, along with industry stakeholders, responded to the proposed LCDs with compelling clinical evidence that is more than sufficient to ensure continued widespread
patient access to our OMNI technology. We will continue to focus on maintaining strong relationships with our customers and executing our strategic initiatives, which we believe will be greatly enhanced by the addition of medtech industry veteran
Matt Link as Chief Commercial Officer. We look forward to continuing to improve the lives of patients with glaucoma and dry eye as we optimize and scale both our Surgical Glaucoma and Dry Eye businesses,&#148; continued Mr. Badawi. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2023 Financial Guidance </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sight Sciences updates revenue
guidance expectations for the full year 2023 to $80.0&nbsp;million to $82.0&nbsp;million, which represents growth of approximately 12% to 15% compared to 2022, from the prior revenue guidance range of $89.0&nbsp;million to $94.0&nbsp;million. The
Company expects the guidance for the third quarter of 2023 is a reasonable expectation for quarterly revenue run rate until customers gain more visibility into </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g507422g0912011808138.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
longer term Medicare coverage for OMNI. Should OMNI procedures remain covered for Medicare beneficiaries after the final LCDs are published, the Company would expect a return to historical growth
rates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company plans to discuss complete third quarter 2023 financial results in early November 2023. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Sight Sciences </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sight Sciences is an eyecare
technology company focused on developing and commercializing innovative solutions intended to transform care and improve patients&#146; lives. Using minimally invasive or <FONT STYLE="white-space:nowrap">non-invasive</FONT> approaches to target the
underlying causes of the world&#146;s most prevalent eye diseases, Sight Sciences seeks to create more effective treatment paradigms that enhance patient care and supplant conventional outdated approaches. The Company&#146;s OMNI<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Surgical System is a MIGS technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma (&#147;POAG&#148;), the world&#146;s leading cause of irreversible
blindness. The Company&#146;s TearCare<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> System technology is 510(k) cleared for the application of localized heat therapy in adult patients with evaporative dry eye disease due to meibomian
gland dysfunction (&#147;MGD&#148;) when used in conjunction with manual expression of the meibomian glands, enabling office-based clearance of gland obstructions by physicians to address the leading cause of dry eye disease. The Company&#146;s SION<SUP
STYLE="font-size:75%; vertical-align:top">&#153;</SUP> Surgical Instrument is a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For more information, visit www.sightsciences.com. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">OMNI and
TearCare are registered trademarks of Sight Sciences. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SION is a trademark of Sight Sciences. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><SUP STYLE="font-size:75%; vertical-align:top">&copy;</SUP> 2023 Sight Sciences. All rights reserved. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release, together
with other statements and information publicly disseminated by the Company, contains certain forward-looking statements within the meaning of Section&nbsp;27A of the Securities Act of 1933, as amended, and Section&nbsp;21E of the Securities Exchange
Act of 1934, as amended. The Company intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 and includes this statement for
purposes of complying with these safe harbor provisions. Any statements made in this press release or during the earnings call that are not statements of historical fact, including statements about our beliefs and expectations, are forward-looking
statements and should be evaluated as such. These statements often include words such as &#147;anticipate,&#148; &#147;expect,&#148; &#147;suggests,&#148; &#147;plan,&#148; &#147;believe,&#148; &#147;intend,&#148; &#147;estimates,&#148;
&#147;targets,&#148; &#147;projects,&#148; &#147;should,&#148; &#147;could,&#148; &#147;would,&#148; &#147;may,&#148; &#147;will,&#148; &#147;forecast&#148; and other similar expressions. We base these forward-looking statements on our current
expectations, plans and assumptions that we have made in light of our experience in the industry, as well as our perceptions of historical trends, current conditions, expected future developments and other factors we believe are appropriate under
the circumstances at such time. Although we believe that these forward-looking statements are based on reasonable assumptions at the time they are made, you should be aware that many factors could affect our business, results of operations and
financial condition and could cause actual results to differ materially from those expressed in the forward-looking statements. These statements are not guarantees of future performance or results. These forward-looking statements include, but are
not limited to, statements concerning the following: the Company&#146;s revised third quarter of 2023 and full year 2023 revenue guidance; the Company&#146;s expectation that revenues in its Dry Eye segment will be slightly down sequentially
primarily due to adjustments in the Company&#146;s <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">go-to-market</FONT></FONT> strategy; expected reduction in new accounts added in the period, due to the Company&#146;s strategy of
building a higher utilization, recurring revenue business model with high quality customers and broad market access; the Company&#146;s expectation that the impact of the proposed LCDs on ordering activity will continue until there is clarity on
longer term coverage by the MACs; the Company&#146;s belief that the effects on ordering activity will prove to be transitory if its products, especially its OMNI<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Surgical System technology,
maintain their current broad coverage upon finalization of the LCDs; the expectation that the Company&#146;s revenues will normalize and return to growth should the final LCDs provide that OMNI procedures remain covered for Medicare beneficiaries in
the affected jurisdictions; the </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g507422g0912011808138.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Company&#146;s continuing focus on maintaining strong relationships with its customers and executing its strategic initiatives, and the belief that these efforts will be enhanced by the addition
of Matt Link as Chief Commercial Officer; optimizing and scaling the Company&#146;s Surgical Glaucoma and Dry Eye businesses; the Company&#146;s expectation that its guidance for the third quarter of 2023 is a reasonable expectation for quarterly
revenue run rate until customers gain more visibility into longer term Medicare coverage for OMNI; the Company&#146;s expectation that if OMNI procedures remain covered for Medicare beneficiaries after the final LCDs are published, then the Company
would expect a return to historical growth rates; and timing for discussion of the Company&#146;s third quarter 2023 financial results. These forward-looking statements are subject to and involve numerous risks, uncertainties and assumptions,
including those discussed under the caption &#147;Risk Factors&#148; in our filings with the U.S. Securities and Exchange Commission, as may be updated from time to time in subsequent filings, and you should not place undue reliance on these
statements. These cautionary statements are made only as of the date of this press release. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as
required by applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor contact: </B> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Philip Taylor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Gilmartin Group </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">415.937.5406 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investor.Relations@Sightsciences.com </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>sght-20230911.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 9/12/2023 12:58:47 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2022"
  xmlns:sght="http://www.sightsciences.com/20230911"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.sightsciences.com/20230911"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sght-20230911_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sght-20230911_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.sightsciences.com//20230911/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>sght-20230911_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 9/12/2023 12:58:47 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine3" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Three</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Three</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>sght-20230911_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 9/12/2023 12:58:47 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.sightsciences.com//20230911/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="sght-20230911.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.sightsciences.com//20230911/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine3" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="47.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g507422g0912011754621.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g507422g0912011754621.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  O &X# 2(  A$! Q$!_\0
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#C__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g507422g0912011808138.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g507422g0912011808138.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  O &X# 2(  A$! Q$!_\0
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#C__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139837901866960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Sep. 11, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001531177<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 11,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Sight Sciences, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40587<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">80-0625749<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">4040 Campbell<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Avenue<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">Suite 100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Menlo Park<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(877)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">266-1144<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SGHT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>d507422d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="sght-20230911.xsd" xlink:type="simple"/>
    <context id="duration_2023-09-11_to_2023-09-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001531177</identifier>
        </entity>
        <period>
            <startDate>2023-09-11</startDate>
            <endDate>2023-09-11</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2023-09-11_to_2023-09-11">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2023-09-11_to_2023-09-11"
      id="Hidden_dei_EntityCentralIndexKey">0001531177</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2023-09-11_to_2023-09-11">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2023-09-11_to_2023-09-11">2023-09-11</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2023-09-11_to_2023-09-11">Sight Sciences, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2023-09-11_to_2023-09-11">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2023-09-11_to_2023-09-11">001-40587</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2023-09-11_to_2023-09-11">80-0625749</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2023-09-11_to_2023-09-11">4040 Campbell</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2023-09-11_to_2023-09-11">Avenue</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3 contextRef="duration_2023-09-11_to_2023-09-11">Suite 100</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown contextRef="duration_2023-09-11_to_2023-09-11">Menlo Park</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2023-09-11_to_2023-09-11">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2023-09-11_to_2023-09-11">94025</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2023-09-11_to_2023-09-11">(877)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2023-09-11_to_2023-09-11">266-1144</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2023-09-11_to_2023-09-11">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2023-09-11_to_2023-09-11">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2023-09-11_to_2023-09-11">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2023-09-11_to_2023-09-11">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2023-09-11_to_2023-09-11">Common Stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-09-11_to_2023-09-11">SGHT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-09-11_to_2023-09-11">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2023-09-11_to_2023-09-11">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="duration_2023-09-11_to_2023-09-11">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" #YB2M7A$-UZXP$  !C$@  &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;(V877.C-A2&_XJ&=CKM3!(0P1]);<]XG60WLYNL&]SN3#N]D$&V-0%$)6$[
M_[Y'X("[Q0??V BDET='1Z^$1CNI7O6&<T/V:9+IL;,Q)K]U71UM>,KTE<QY
M!D]64J7,0%&M79TKSN*R49JXON?UW92)S)F,RGMS-1G)PB0BXW-%=)&F3+U]
MX(G<C1WJO-]X$>N-L3?<R2AG:QYR\WL^5U!R:Y58I#S30F9$\=78F=+;#_[
M-BAK_"'X3A]=$]N5I92OMO 8CQW/$O&$1\9*,/C;\AE/$JL$'/\<1)WZG;;A
M\?6[^D/9>>C,DFD^D\DW$9O-V!DZ).8K5B3F1>X^\4.'>E8ODHDN?\FNJAMX
M#HD*;61Z: P$J<BJ?[8_!.*X 3W1P#\T\$ONZD4EY1TS;#)2<D>4K0UJ]J+L
M:MD:X$1F1R4T"IX*:&<F=S(J(,B&L"PF]YD1YHT\9M5H0]1&KH&7V*IN=!#\
M4 GZ)P1#GE\12B^([_G7_VWN EL-Z-> ?JEW?4)O)K=<D;^F2VT4#.'?;425
M0M"N8//Z5N<LXF,'$E=SM>7.Y*<?:-_[%>&[KOFN,?7)%*(7EQ%\2-BZC0YO
MOV*)Y@A'4',$J,YA[&9 HE@"8QCS/?G,W]J(<"7/\VCOFM+! ,'JU5@]5*S.
MK\5;SMM8\.;#R\\(1+^&Z)\',>=*2)OG,8'9TLJ#*]79W97>@QIM<,ZPO?"U
ML D.C,\L;07#=4+K/B2,!,\BKB]@_*,K!&]8XPW/P0,UJ7*I2D\@H8'8D9DL
M(-4@XV3<RHL+W]TC=#<UW<TY= \BX>2Y2)=<M8'@&I#LEX'7&V+)3KW&3;US
MB!9L3QYCR#BQ$E$5M--\'9)#[]+K^[U!<(,1'OD]/8=P&L?@A9 HAPOR!>J1
MKUGK4'9(!E[@D1E+\R4LKAADX_D4M6P<<K&3K9"XY'3+LP(S6MHX/L4M&Z?;
M*-X>1%PT+ 1,*NIY&&*S&-"S5H,:<69+4I&%W+6OZ;C<$\\22>9,O6)TS9I
M<5?_GJXR%,";*[D58&"MB+CF;(JA-2L%Q0W^>[2YU :6TS]%?M+H.A1O L_O
M86S-4D%QCR\'<0I[[],HN,#/P\'@%PRE618H;M]?9 11F6]DACEOAXC?[U]2
M&@084;,44-S'OREA#,\@-&E:9 ?7U:U4N%#7ALQO%@,?=^Y0)B(21F1K\@0)
MK@1+VG@Z5#IY&NOW<9^>*UZ&QVX1JCT9;%UA<_UUM6H?OPZ]3K*C/3YNSO\C
M>]2Z +).0%RV$["Q?+_#G7E4*#O]J+\D"V&2UNG7(6)[6&Z?9/1Z07[TKF#O
M07*FR)8E!2<Y]%1OF$*)FQ7 QRU[H5AL,R]\2Y>R/>]P@?#CIP5&TKB]CSMS
M';O[?;1AV9J?W.)V"#U/P[OI;QA38_/^639_GW*UME'Z" IF8W,P9UGK-U.'
MH%'HYL)O3-X_ZX/@?D]@!#,MRLUC]=W2BH6KG9P![M&1@3U^>6(V$)HD? 5"
MWM4 AD)5)QI5P<B\/$582F-D6EYN.(/9:2O \Y64YKU@#R;J<Z7)OU!+ P04
M    " #YB2M7GZ ;\+$"  #B#   #0   'AL+W-T>6QE<RYX;6S=5VUKVS 0
M_BM"/V!N8FKBD1BV0&&PC4+S85^56'8$>O%DN7/ZZZ>S;"=I=67=A['-H<G=
M/;J[1W<GF:Y;=Y+\X<BY([V2NMW0HW/-^R1I#T>N6/O.-%Q[I#)6,>=56R=M
M8SDK6W!2,EG>W&2)8D+38JT[=:=<2PZFTVY#;VA2K"NCSY:4!H-?RA0GCTQN
MZ)9)L;=B6,N4D*=@7H+A8*2QQ'DJ?$,78&F? KP(&K <XRBAC05C$C*$[_VX
M_!DP::U7A90SP24-AF+=,.>XU7=>&18/QA<0&>7=J?$,:\M.B^4M/3L,/S[)
MWMB2VSG-@DZF8BUY!72LJ(_PZTR3 .B<45XH!:N-9@.'R6,4?-@#E_(!6OBM
MNHK=5R3TXE,);2"PU4GTA$8QA D*Q+^,%F)?A+W]K;"D$8_&?>S\;O2@?^^,
MX_>65Z(?]+Z:\V/1%WATUC3R]$&*6BL>]O[+"8LUF_S(T5CQY+/!I!R\@5M*
M'KEUXG!I^6%9L^.]FZ:IKW#.RW^0\Y^M<\TUMTQ>DO:C_S=7^2V,D_'T7!S1
MJP,Z6PE<A!OZ%>Y7>>9 ]IV03NA1.XJRY/K%.?7A'=O["_PJOE]?\HIUTNUF
M<$//\A=>BD[E\ZI[J,NXZBQ_AOMHD<VWL,\E=,E[7FY'U=;[021>\%G'!QR>
M(W?#$T<PGX#%$<"P/!@#S"=X87G^I_VLT/T$#..VBB(KU&>%^@2O&+(=/EB>
MN$_NG_A.\SQ-LPRKZ'8;9;#%ZI9E\!>/AG$##RP/9'I;K?%NXQ/R^AQ@/7UM
M0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q _G@>F*FX3YI"5S%NV G&D3S'
M$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"IQ%', ;  4/2='@//GL?)=-[
M*CG_5U/\!%!+ P04    " #YB2M7EXJ[',     3 @  "P   %]R96QS+RYR
M96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY
M/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL
M/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%
MY4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.
MW&,EC'%BM/XU@LD/['X 4$L#!!0    ( /F)*U<<.&7J/P$  #P"   /
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MDWM)J'7N0;#W\!J-'<V/'[?\ 5!+ P04    " #YB2M7)!Z;HJT   #X 0
M&@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4 -5"I
M0P5,75@K+A %\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=NH+;S)$9K!LID
MR^SO *1;M(HNSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFBG#S^0W1UW6E\
M./VR./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6
M?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ ^8DK5V60>9(9 0
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M<',O87!P+GAM;%!+ 0(4 Q0    ( /F)*U<=[N,[[P   "L"   1
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M96QS+RYR96QS4$L! A0#%     @ ^8DK5QPX9>H_ 0  / (   \
M     ( !E1   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( /F)*U<D'INB
MK0   /@!   :              "  0$2  !X;"]?<F5L<R]W;W)K8F]O:RYX
M;6PN<F5L<U!+ 0(4 Q0    ( /F)*U=ED'F2&0$  ,\#   3
M  "  >82  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  # 4
$      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>25</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d507422d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sightsciences.com//20230911/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d507422d8k.htm">d507422d8k.htm</File>
    <File>d507422dex991.htm</File>
    <File>d507422dex992.htm</File>
    <File>sght-20230911.xsd</File>
    <File>sght-20230911_lab.xml</File>
    <File>sght-20230911_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d507422d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 25
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d507422d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "sght-20230911_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "sght-20230911_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "sght-20230911.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd"
     ]
    }
   },
   "elementCount": 26,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 25,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "sght",
   "nsuri": "http://www.sightsciences.com/20230911",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d507422d8k.htm",
      "contextRef": "duration_2023-09-11_to_2023-09-11",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.sightsciences.com//20230911/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d507422d8k.htm",
      "contextRef": "duration_2023-09-11_to_2023-09-11",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sightsciences.com//20230911/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sightsciences.com//20230911/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sightsciences.com//20230911/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sightsciences.com//20230911/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sightsciences.com//20230911/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sightsciences.com//20230911/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three",
        "terseLabel": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sightsciences.com//20230911/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sightsciences.com//20230911/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sightsciences.com//20230911/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sightsciences.com//20230911/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sightsciences.com//20230911/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sightsciences.com//20230911/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sightsciences.com//20230911/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sightsciences.com//20230911/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sightsciences.com//20230911/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sightsciences.com//20230911/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sightsciences.com//20230911/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sightsciences.com//20230911/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sightsciences.com//20230911/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sightsciences.com//20230911/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sightsciences.com//20230911/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sightsciences.com//20230911/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sightsciences.com//20230911/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sightsciences.com//20230911/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sightsciences.com//20230911/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001193125-23-232585-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-232585-xbrl.zip
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M^DS,^"C,-MO"5=X[M)G"M#6, VL18?4[[JRL")F;W4J6O5GM($XV^FKX>6J
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M8F^F>G)0:! XG(0QR5 LH,&A--I"C2WNHF<BBQ043!5W6Y4'"TP;0I@']8@
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M[[]\W=]]M?7+<_,6]->_"8GZ;X/V6.8!Y =E7[_[#0_Y;Z3_#5!+ P04
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M9YEM#G-W,QSZ]JI=.O3S7U!+ P04    " #YB2M7J6Z(ELL&  "D3   %0
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MM\7WAMH_XZN116(]?S!6%(*L$N2ED)[Q.;2A><C7V O*"*SE;PX64W4W,?M
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MS"GT]17S9,Y48\L_4$L! A0#%     @ ^8DK5\[6P=Y!&0  0(H   X
M         ( !     &0U,#<T,C)D.&LN:'1M4$L! A0#%     @ ^8DK5\NO
M,B>(#P  SBT  !$              ( !;1D  &0U,#<T,C)D97@Y.3$N:'1M
M4$L! A0#%     @ ^8DK5['7/\P\$@  *CT  !$              ( !)"D
M &0U,#<T,C)D97@Y.3(N:'1M4$L! A0#%     @ ^8DK5QM9UH1  P  7 L
M !$              ( !CSL  '-G:'0M,C R,S Y,3$N>'-D4$L! A0#%
M  @ ^8DK5ZENB);+!@  I$P  !4              ( !_CX  '-G:'0M,C R
M,S Y,3%?;&%B+GAM;%!+ 0(4 Q0    ( /F)*U<=FO</[ 0  ,TO   5
M          "  ?Q%  !S9VAT+3(P,C,P.3$Q7W!R92YX;6Q02P4&      8
,!@!_ 0  &TL

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
